Recombinant human insulin-like growth factor I (mecasermin)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant human insulin-like growth factor I (mecasermin), covering 2015-03-25 to 2015-03-25. Get the full timeline:
Most recent: Clinical Trial Update: Study of Recombinant Human Insulin-Like Growth Factor I in Patients With Severe Insulin Resistance [NA]